## Correct Answer: A. Hyperparathyroidism Calcitonin is a 32-amino acid peptide hormone produced by the parafollicular C cells of the thyroid gland. Its primary physiological role is to lower serum calcium levels by inhibiting osteoclast activity and promoting renal calcium excretion. In **hyperparathyroidism**, sustained elevation of serum calcium (hypercalcemia) triggers a compensatory increase in calcitonin secretion as a negative feedback mechanism to counteract the hypercalcemic state. This is a direct physiological response: high calcium → C-cell stimulation → increased calcitonin production. The magnitude of calcitonin elevation correlates with the degree of hypercalcemia. This is particularly relevant in primary hyperparathyroidism, the most common cause of hypercalcemia in ambulatory Indian populations (after vitamin D intoxication and tuberculosis-related hypercalcemia). The elevated calcitonin represents the body's attempt to restore calcium homeostasis, making it a secondary (reactive) elevation rather than a primary endocrine disorder. This compensatory mechanism is clinically important because calcitonin levels can be used diagnostically to assess the severity of hypercalcemia and monitor treatment response in hyperparathyroidism. ## Why the other options are wrong **B. Hypoparathyroidism** — In hypoparathyroidism, serum calcium is LOW (hypocalcemia), which actually **suppresses** calcitonin secretion rather than stimulating it. Calcitonin's role is to lower calcium, so it is not needed when calcium is already low. Patients with hypoparathyroidism have decreased calcitonin levels, not increased. This is the opposite physiological scenario from hyperparathyroidism. **C. Hyperthyroidism** — Hyperthyroidism involves increased thyroid hormone (T3/T4) production but does NOT directly stimulate C-cell calcitonin secretion. Calcitonin secretion is regulated by serum calcium levels, not by thyroid hormone status. While hyperthyroidism may indirectly affect bone metabolism and calcium homeostasis, it does not cause primary elevation of calcitonin. This is a common NBE trap confusing thyroid pathology with calcitonin regulation. **D. Cushing's syndrome** — Cushing's syndrome (excess cortisol) causes hypercalcemia through increased bone resorption and altered vitamin D metabolism, but calcitonin is not the primary hormonal abnormality. While secondary hypercalcemia might trigger some calcitonin response, Cushing's syndrome is not classically associated with elevated calcitonin levels. The primary endocrine derangement involves cortisol and ACTH, not calcitonin regulation. ## High-Yield Facts - **Calcitonin regulation**: Serum calcium is the PRIMARY stimulus for C-cell secretion; high calcium → increased calcitonin (negative feedback). - **Hyperparathyroidism + hypercalcemia**: Sustained elevation of serum calcium triggers compensatory calcitonin rise as a homeostatic response. - **C-cell origin**: Calcitonin is produced by parafollicular (C) cells of the thyroid, NOT by parathyroid glands (which produce PTH). - **Calcitonin's action**: Inhibits osteoclasts, promotes renal calcium excretion, and lowers serum calcium—opposite to PTH effect. - **Clinical pearl**: In medullary thyroid carcinoma (MTC), calcitonin is markedly elevated due to C-cell malignancy; this is the ONLY primary endocrine cause of high calcitonin in India. ## Mnemonics **CALCITONIN = Calcium DOWN** Calcitonin lowers calcium by inhibiting osteoclasts and increasing renal excretion. When serum calcium is HIGH (hyperparathyroidism), the body releases MORE calcitonin to bring it down. Think: High Ca → High Calcitonin (compensatory). **C-cells = Calcium sensors** Parafollicular C cells of thyroid sense serum calcium directly. High calcium → C-cell stimulation → calcitonin surge. This is the ONLY physiological stimulus for calcitonin in non-malignant states. ## NBE Trap NBE pairs thyroid pathology (hyperthyroidism) with calcitonin to trap students who confuse thyroid hormone regulation with calcium homeostasis. Calcitonin is regulated by **serum calcium**, not by TSH or thyroid hormones—a critical distinction often missed in rapid reading. ## Clinical Pearl In Indian clinical practice, when a patient with primary hyperparathyroidism (often detected incidentally on biochemistry screening) presents with hypercalcemia, measuring calcitonin helps assess the severity of the hypercalcemic state and guides intensity of treatment. Paradoxically, the body's own calcitonin is trying to protect the patient from severe hypercalcemia—a beautiful example of homeostatic compensation. _Reference: Harrison Ch. 405 (Disorders of Parathyroid Gland); KD Tripathi Ch. 32 (Thyroid and Parathyroid Hormones)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.